UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035520
Receipt number R000040468
Scientific Title Elucidation of effects of chronic exercise on novel peptide hormones to prevent sarcopenia and chronic diseases
Date of disclosure of the study information 2019/01/11
Last modified on 2024/01/16 10:51:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of effects of chronic exercise on novel peptide hormones to prevent sarcopenia and chronic diseases

Acronym

Elucidation of effects of chronic exercise on novel peptide hormones to prevent sarcopenia and chronic diseases

Scientific Title

Elucidation of effects of chronic exercise on novel peptide hormones to prevent sarcopenia and chronic diseases

Scientific Title:Acronym

Elucidation of effects of chronic exercise on novel peptide hormones to prevent sarcopenia and chronic diseases

Region

Japan


Condition

Condition

Young and Middle-aged and older adults including of obese adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to evaluate whether chronic exercise modulates circulating peptide hormone levels to prevent sarcopenia and chronic diseases.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Effects of chronic exercise on circulating peptide hormone levels

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Young subjects undertook a chronic aerobic exercise using cycle ergometer. The aerobic exercise-training program consisted of cycling on a leg ergometer for 45-55 min, 60-70% of maximal oxygen uptake, 3 days/week, for 8-12 weeks.

Interventions/Control_2

Middle-aged and older subjects undertook a chronic aerobic exercise using cycle ergometer. The aerobic exercise-training program consisted of cycling on a leg ergometer for 45-55 min, 60-70% of maximal oxygen uptake, 3 days/week, for 8-12 weeks.

Interventions/Control_3

Young subjects undertook a chronic resistance exercise. The resistance exercise-training program to whole body consisted for 10 repetitions, 3 sets, 60-70% of repetition maximum, 3 days/week, for 8-12 weeks.

Interventions/Control_4

Middle-aged and older subjects undertook a chronic resistance exercise. The resistance exercise-training program to whole body consisted for 10 repetitions, 3 sets, 60-70% of repetition maximum, 3 days/week, for 8-12 weeks.

Interventions/Control_5

Non intervention(Young subjects)

Interventions/Control_6

Non intervention(Middle-aged and older subjects)

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Subjects who must ban or limit exercise therapy by the doctor
2)Subjects who don't have some therapies and/or medications
3)Subjects who are capable of making a decision by themselves, and provide written consent

Key exclusion criteria

1)Patients with hepatic dysfunction and/or renal dysfunction
2)Patients with cardiovascular diseases
3)Pregnant or plans to become pregnant during the study period
4)Patients with limited exercise therapy
5)Others who judged inappropriate by the examining physician

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Motoyuki
Middle name
Last name Iemitsu

Organization

Ritsumeikan University

Division name

Faculty of Sport and Health Science

Zip code

525-8577

Address

1-1-1 Noji-higashi, Kusatsu, Shiga

TEL

077-599-4131

Email

iemitsu@fc.ritsumei.ac.jp


Public contact

Name of contact person

1st name Motoyuki
Middle name
Last name Iemitsu

Organization

Ritsumeikan University

Division name

Faculty of Sport and Health Science

Zip code

525-8577

Address

1-1-1 Noji-higashi, Kusatsu, Shiga

TEL

077-599-4131

Homepage URL


Email

iemitsu@fc.ritsumei.ac.jp


Sponsor or person

Institute

Ritsumeikan University

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ritsumeikan University

Address

1-1-1 Noji-higashi, Kusatsu, Shiga

Tel

077-561-3412

Email

b-rinri@st.ritsumei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 11 Day


Related information

URL releasing protocol

https://www.aging-us.com/article/102678/text

Publication of results

Unpublished


Result

URL related to results and publications

https://www.aging-us.com/article/102678/text

Number of participants that the trial has enrolled

76

Results

Aerobic training in the young adults reduced arterial stiffness, but circulating salusin-alpha level did not change.
Aerobic training in the middle-aged and older adults reduced arterial stiffness with an increase in circulating salusin-alpha level.
The change in arterial stiffness before and after interventons was associated with circulating salusin-alpha levels.

Results date posted

2024 Year 01 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

healthy 36 young and 40 middle-aged and older adults

Participant flow

This subdivision resulted in the formation of four groups: a Young-Training group, a Young control group, a Middle-aged and older-Training group, and a Middle-aged and older-Con group. In the training groups, subjects underwent eight weeks of aerobic exercise training.

Adverse events

None

Outcome measures

arterial stiffness, circulating salusin level, maximal oxygen uptake

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 01 Day

Date of IRB

2017 Year 09 Month 29 Day

Anticipated trial start date

2018 Year 01 Month 11 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 11 Day

Last modified on

2024 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040468


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name